White label ELPA - ClinicalTrials.eu

Study on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension

Recruiting

2 1 1 1
Investigated Diseases:
- Hepatic cirrhosis
Investigated Drugs:
- Carvedilol
Study on Meropenem Dosing for Patients with Serious Infections in Intensive Care

Recruiting

3 1 1 1
Investigated Diseases:
- Sepsis
Investigated Drugs:
- Linezolid
Study on Preventing Atrial Fibrillation After Heart Surgery Using Landiolol Hydrochloride in Patients with Normal Heart Function

Recruiting

3 1 1
Investigated Diseases:
- Ejection fraction normal
- Sinus rhythm
Investigated Drugs:
- Landiolol Hydrochloride
Study on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years

Recruiting

3 1 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- Dupilumab
A study of ruxolitinib as first treatment for children with haemophagocytic lymphohistiocytosis (HLH)

Recruiting

2 1 1 1
Investigated Diseases:
- Haemophagocytic lymphohistiocytosis
Investigated Drugs:
- Ruxolitinib
Study on the Safety and Effectiveness of ARI0002h and Drug Combination for Newly Diagnosed Primary Plasma Cell Leukemia Patients

Recruiting

2 1 1 1
Investigated Drugs:
Study on the Effectiveness and Safety of Deucravacitinib for Children and Teens with Juvenile Psoriatic Arthritis

Recruiting

3 1
Investigated Diseases:
- Still’s disease
- Juvenile idiopathic arthritis
Investigated Drugs:
- Deucravacitinib
Study of SGT-003 Gene Therapy for Safety and Tolerability in Walking Males with Duchenne Muscular Dystrophy

Recruiting

2 1 1
Investigated Drugs:
- SGT-003
Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

Recruiting

3 1
Investigated Drugs:
- SELTOREXANT
+3
Study on the Safety and Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Adults with Severe or Moderately Severe Hemophilia B and AAV5 Antibodies

Recruiting

3 1 1 1
Investigated Diseases:
- Factor IX deficiency
Investigated Drugs:
- Etranacogene Dezaparvovec

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies